APA
HEPA

American Portfolios Advisors’s Hepion Pharmaceuticals HEPA Stock Holding History

American Portfolios Advisors’s Portfolio HEPA Stock Details HEPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2
Closed -$10.7K – 2835
2019
Q4 		$10.7K Buy
+2
New +$7.74K ﹤0.01% 1969

Other funds holding HEPA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Portfolios Advisors's HEPA Position: Q1 2020 in Review

American Portfolios Advisors sold out of Hepion Pharmaceuticals (HEPA) in Q1 2020, closing a stake of 2 shares — an estimated $10.7K sold.

American Portfolios Advisors first reported a position in HEPA in Q4 2019 and held it in 1 quarter. The position peaked at $10.7K in Q4 2019. 6 funds tracked by Wall St. Rank hold HEPA as of Q1 2020.

  • American Portfolios Advisors reported no remaining Hepion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • American Portfolios Advisors sold 2 Hepion Pharmaceuticals shares in Q1 2020, an estimated $10.7K.
  • American Portfolios Advisors first reported a position in Hepion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • American Portfolios Advisors's Hepion Pharmaceuticals position peaked at $10.7K in Q4 2019.
  • 6 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q1 2020.

Based on American Portfolios Advisors's 13F filing for Q1 2020, filed 24 Mar 2023.